A genome wide association study of Plasmodium falciparum susceptibility to 22 antimalarial drugs in Kenya

A genome wide association study of Plasmodium falciparum susceptibility to 22 antimalarial drugs in Kenya

BACKGROUND: Drug resistance remains a chief concern for malaria control. In order to determine the genetic markers of drug resistant parasites, we tested the genome-wide associations (GWA) of sequence-based genotypes from 35 Kenyan P. falciparum parasites with the activities of 22 antimalarial drugs...

Bibliografski detalji
Glavni autori:	Wendler, J, Okombo, J, Amato, R, Miotto, O, Kiara, S, Mwai, L, Pole, L, O'Brien, J, Manske, M, Alcock, D, Drury, E, Sanders, M, Oyola, S, Malangone, C, Jyothi, D, Miles, A, Rockett, K, Macinnis, B, Marsh, K, Bejon, P, Nzila, A, Kwiatkowski, D
Format:	Journal article
Jezik:	English
Izdano:	Public Library of Science 2014

Slični predmeti

A genome wide association study of Plasmodium falciparum susceptibility to 22 antimalarial drugs in Kenya.
od: Jason P Wendler, i dr.
Izdano: (2014-01-01)

The MSPDBL2 codon 591 polymorphism is associated with lumefantrine in vitro drug responses in Plasmodium falciparum isolates from Kilifi, Kenya.
od: Ochola-Oyier, L, i dr.
Izdano: (2014)

Characterization of within-host Plasmodium falciparum diversity using next-generation sequence data.
od: Auburn, S, i dr.
Izdano: (2012)

In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1.
od: Mwai, L, i dr.
Izdano: (2009)

Efficient depletion of host DNA contamination in malaria clinical sequencing.
od: Oyola, S, i dr.
Izdano: (2013)

Genome-wide screen identifies new candidate genes associated with artemisinin susceptibility in Plasmodium falciparum in Kenya
od: Borrmann, S, i dr.
Izdano: (2013)

Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal Kenya.
od: Okombo, J, i dr.
Izdano: (2014)

Optimized Whole-Genome Amplification Strategy for Extremely AT-Biased Template.
od: Oyola, S, i dr.
Izdano: (2014)

Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal Kenya
od: John Okombo, i dr.
Izdano: (2014-12-01)

The activities of various antimalarial drugs on Plasmodium falciparum isolates in Kilifi Kenya and studies on mechanisms of resistance
od: Mwai, L
Izdano: (2011)

An effective method to purify Plasmodium falciparum DNA directly from clinical blood samples for whole genome high-throughput sequencing
od: Auburn, S, i dr.
Izdano: (2011)

Optimizing Illumina next-generation sequencing library preparation for extremely AT-biased genomes.
od: Oyola, S, i dr.
Izdano: (2012)

Genetic polymorphisms associated with antimalarial antibody levels in a low and unstable malaria transmission area in southern Sri Lanka.
od: Dewasurendra, R, i dr.
Izdano: (2012)

Anticancer agents against malaria: time to revisit?
od: Nzila, A, i dr.
Izdano: (2010)

Chloroquine resistance before and after its withdrawal in Kenya.
od: Mwai, L, i dr.
Izdano: (2009)

Genetic markers associated with dihydroartemisinin–piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study
od: Kwiatkowski, D, i dr.
Izdano: (2016)

Whole genome sequencing of Plasmodium falciparum from dried blood spots using selective whole genome amplification
od: Oyola, S, i dr.
Izdano: (2016)

Prioritization of Molecular Targets for Antimalarial Drug Discovery
od: Forte, Barbara, i dr.
Izdano: (2023)

Memory B cells are a more reliable archive for historical antimalarial responses than plasma antibodies in no-longer exposed children.
od: Ndungu, F, i dr.
Izdano: (2012)

Antimalarial drug quality in Gabon
od: B.J. Visser, i dr.
Izdano: (2014-04-01)

Antimalarial drugs and the prevalence of mental and neurological manifestations: A systematic review and meta-analysis.
od: Bitta, M, i dr.
Izdano: (2017)

Pharmacovigilance of antimalarial treatment in Africa: is it possible?
od: Staedke Sarah G, i dr.
Izdano: (2006-06-01)

Characterization of within-host Plasmodium falciparum diversity using next-generation sequence data.
od: Sarah Auburn, i dr.
Izdano: (2012-01-01)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
od: Olliaro Piero, i dr.
Izdano: (2007-09-01)

Optimizing illumina next-generation sequencing library preparation for extremely at-biased genomes
od: Oyola Samuel O, i dr.
Izdano: (2012-01-01)

Comparison of allele frequencies of Plasmodium falciparum merozoite antigens in malaria infections sampled in different years in a Kenyan population.
od: Ochola-Oyier, L, i dr.
Izdano: (2016)

SNP-o-matic.
od: Manske, H, i dr.
Izdano: (2009)

The antimalarial ferroquine: from bench to clinic.
od: Biot, C, i dr.
Izdano: (2011)

The antimalarial ferroquine: from bench to clinic
od: Biot C., i dr.
Izdano: (2011-08-01)

Discovery of new targets for antimalarial chemotherapy
od: Grellier P., i dr.
Izdano: (2008-09-01)

Chloroquine resistance before and after its withdrawal in Kenya
od: Marsh Kevin, i dr.
Izdano: (2009-05-01)

Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study
od: Amato, R, i dr.
Izdano: (2018)

The difference between effectiveness and efficacy of antimalarial drugs in Kenya.
od: Amin, A, i dr.
Izdano: (2004)

Whole-genome scans provide evidence of adaptive evolution in Malawian Plasmodium falciparum isolates.
od: Ocholla, H, i dr.
Izdano: (2014)

Effectiveness of antimalarial drugs.
od: Baird, J
Izdano: (2005)

World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs.
od: Price, R, i dr.
Izdano: (2007)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
od: Price, R, i dr.
Izdano: (2007)

Novel antimalarial targets and the antimalarial pipeline
od: K. Chibale
Izdano: (2014-04-01)

Cajachalcone: An Antimalarial Compound from Cajanus cajan Leaf Extract
od: E. O. Ajaiyeoba, i dr.
Izdano: (2013-01-01)

Synergistic action of cytokines and purified respiratory syncytial virus in nitric oxide induction.
od: Hacking, D, i dr.
Izdano: (2002)